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Content Validation of a Home Parenteral Nutrition Patient Reported Outcome Questionnaire 
 
Abstract 
Background:  Patient reported outcome (PRO) instruments collect information from patients 
about health conditions and disease management including quality of life (QOL).  Clinicians 
acknowledge patient concerns about QOL but need guidance to assess the nature and severity of 
individually experienced problems.  The Home Parenteral Nutrition (HPN) Patient Reported 
Outcome Questionnaire (HPN-PROQ) was developed for use during medical appointments or 
homecare visits to address this gap.  The purpose of this research was to provide evidence that 
the HPN-PROQ items and scale possess content validity. 
Methods:  A mixed method study design was used.  In phase 1, cognitive interviews (CI) were 
conducted with 32 HPN patients.  Thematic analysis was used to assess participant 
understanding of the instructions, items, and response scales and overall utility of the HPN-
PROQ.  In phase 2, 13 expert clinicians evaluated the relevance of items to the HPN population 
using the Content Validity Index (CVI) to produce item-level (I-CVI) and scale-level (S-CVI) 
scores.  Items with an I-CVI score > 0.783 were retained.  
Results:  Fifty-four percent of items were deemed as being comprehensible, acceptable, and 
clear; 25% were revised, and 11% were deleted.  In phase 2, 79% of items were rated highly 
relevant.  The S-CVI score was 0.96.  The final HPN-PROQ contains 34 items. 
Conclusion:  This study established acceptable content validity of the HPN-PROQ.  This PRO 
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Background 
 Home parenteral nutrition (HPN) is a complex therapy involving the intravenous infusion 
of nutrients and fluids to individuals who have intestinal failure or dysfunction.  Home-based 
care, with support from family members and trained healthcare professionals, provides patients 
the opportunity to receive nutritional support in a familiar and comfortable environment outside 
of a hospital or institutional setting.  There are, however, known factors that negatively affect the 
quality of life (QOL) of HPN patients including decreased physical, psychological and social 
function along with increased occurrences of depression, drug dependency, sleep disturbance, 
frequent urination, fear of therapy related complications, inability to eat, and financial distress.1-7 
Furthermore, the emotional and physical complications associated with HPN and underlying 
disease require extensive lifestyle adaptation for patients and their families. 4,8,9  
At present, there is one validated therapy-specific instrument (HPN-QOL©)10 to support 
the HPN population, however, data from the Sustain Registry indicated less than 2% of enrolled 
HPN patients reported having QOL measured.11 Three research reports have been published 
using the HPN-QOL© to assess changes among HPN patients with short bowel syndrome 
receiving teduglutide12,13 and among patients undergoing intestinal transplantation.14  A recently 
developed shorter self assessment version highly correlated with the HPN-QOL© but not with 
patients' physical symptoms during HPN.15  Quality of life assessment should become part of 
routine clinical management of HPN patients, but no specific time frame or frequency of 
conducting an evaluation has been suggested.5,10,12,13  To the authors’ knowledge, there have 
been no published reports using the HPN-QOL© to facilitate communication between healthcare 
providers and patients.   
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 Previous research revealed that HPN patients perceive their routine medical appointments 
as a parenteral nutrition "tune-up" with sessions focusing primarily on medical or disease aspects 
of care, although they would prefer a more holistic approach with emotional support in addition 
to medical examination and nutritional assessment.16 One such tool to help in this regard is a 
patient reported outcome (PRO) questionnaire.  PRO questionnaires can be used to collect 
information about a patient's health condition and management including QOL, satisfaction, and 
adherence to medical regimens.17,18 PROs may also be used to screen for functional problems, 
assess and improve quality of health care, and improve patient-clinician communication while 
expanding the role of shared or informed decision-making.19 When PRO instruments are used in 
clinical practice, feedback is provided to the clinician with the goal of helping to manage patient 
care.  Such instruments can be invaluable in facilitating patient-clinician communication around 
QOL and can improve the interactions between patients and their clinicians.17  
 Because there is no known PRO instrument being used in clinical practice, we developed 
the Home Parenteral Nutrition-Patient Reported Outcome Questionnaire (HPN-PROQ) for 
patients to self-assess factors that influence QOL or adaptation to HPN. The HPN-PROQ was 
developed after a series of research activities including comprehensive literature review, expert 
clinician feedback, and an exploration of the lived experiences of HPN dependent adults. 1,16,20,21 
This work established a definition for QOL (“doing what I want to do when I want to do it”) and 
identified factors influencing QOL; eating and mealtime participation, gastrointestinal symptoms, 
energy level, and ability to do activities of daily living, sleep, psychosocial function and coping, 
technology burden and training for HPN.16,20 The HPN-PROQ in its initial form included 54 
items with a 4-point Likert response scale.  
 A crucial step in the development of questionnaires is to provide evidence that the items 
and scales possess content validity.22 When testing a new instrument there are two primary 
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components of importance.23-25 First, what is the intent of the question and what do respondents 
believe the question is asking?  Second, what do specific terms, words, and phrases mean, and is 
that meaning consistent with the question’s intent?  As PRO instruments assess concepts most 
relevant and important to a patient, content validity must be established to determine the extent 
to which an instrument assesses the concepts it proposes to assess.25 The primary aim of this 
study was to determine the content validity of the HPN-PROQ through cognitive interviewing 
(CI) with HPN patients and computation of the Content Validity Index (CVI) with expert HPN 
clinicians.   
Methods 
 A mixed method design using qualitative data (CI) and quantitative methods (CVI) was 
employed in this study.23-30 The purpose was to modify an initial draft of the HPN-PROQ based 
on CI with HPN patients and thematic analysis (phase 1), followed by establishment of item and 
scale relevance by expert HPN clinicians using the CVI (phase 2) to produce a final content valid 
questionnaire.   The study protocol was reviewed and approved by the University of Rhode 
Island Institutional Review Board. 
Participants  
 For phase 1, participants were recruited from the Oley Foundation [a national, 
independent, non-profit 501(c)(3) organization for home enteral and parenteral nutrition] via 
email blast and a call for volunteers in their newsletter as done in other similar studies.20,31  
Eligibility requirements included being >18 years of age, receiving HPN, English-speaking, 
living in the US, and having the ability to access a computer while simultaneously being on the 
telephone. Individuals participating in phase 1 interviews completed a brief demographic survey 
that assessed age, sex, race, highest level of education, medical diagnosis, length of HPN-
dependency, number of parenteral nutrition infusions per week and infusion hours per day.  
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Descriptive statistical analysis was conducted using Microsoft Office Excel (2017) and results 
are reported as frequency, mean + standard deviation, and range. 
 For phase 2, 33 expert HPN clinicians, stratified by discipline/profession, were invited to 
participate.  Experts were identified through publications on the topic of HPN, leadership in the 
American Society for Parenteral and Enteral Nutrition home care section, and membership in the 
Oley Foundation.  The goal was to recruit 12 expert physicians, registered dietitians, pharmacists, 
registered nurses, and home care advocates, as this is an acceptable sample size for completion 
of the CVI and is comparable to other studies.29,30,32,33   
Phase 1 - Cognitive Interviews 
 One researcher conducted all interviews by telephone at a time convenient for the 
participant using a semi-structured interview guide with probes.26,27  The interviewer read each 
statement (PRO item) aloud and participants were asked to explain what the statement meant and 
to repeat the statement in their own words.  The interviewer focused on the interpretation of 
words and phrases rather than considering how the participant would answer the actual question.  
All interviews were audio-recorded and transcribed verbatim with all identifiers removed.  
Transcripts were organized on an item-by-item basis.  A cross-interview data matrix table was 
developed to aggregate narratives pertaining to each PRO item and to identify similar patterns 
and interpretations.  An iterative process was used to analyze the data according to the methods 
described in similar research.20,31 Thematic analysis was used to sort and condense findings into 
themes, support decisions for revision of the HPN-PROQ, and identify problematic items.34  
Data are presented as representative quotations to illuminate each theme. 
 Interviews were conducted in two rounds; round 1 tested the instructions, items, and 
response scale of the draft HPN-PROQ, and round 2 tested subsequent revisions made to the 
questionnaire. Member checking, a technique used to validate data collected in interviews by 
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checking summaries or key points participants made before subsequent rounds of interviews or 
study termination, was used.35-37   
Phase 2 - Content Validity Index 
 Thirteen expert clinicians participated in an initial round of evaluation by completing a 
CVI worksheet.  A reduced panel of experts (n=4) participated in a second round of evaluations.  
The item-level (I-CVI) score was calculated by having the expert clinicians rate the relevance of 
each item on the HPN-PROQ, where 1=not relevant, 2=somewhat relevant, 3=quite relevant, and 
4=highly relevant.  The I-CVI is defined as the number of expert clinicians selecting a rating of 
"3" or "4" on each item, divided by the total number of expert clinicians and expresses the 
proportion of agreement by all experts on the relevancy of each item, as a number between 0 and 
1.30 To account for chance agreement, a kappa (K) statistic was calculated for I-CVI scores.28 An 
item with high relevance achieved a K > 0.783.38 Items < 0.783 were removed from the 
questionnaire.  The average of the I-CVI scores was used to designate the scale-level (S-CVI) 
score; K > 0.83 was deemed acceptable.29 
Results 
Phase 1 - Cognitive Interviews 
 A total of 55 adult HPN patients responded to the recruitment announcement, 78% 
completed eligibility screening, and 69% were eligible to participate.  The final sample included 
32 participants, as interviews were stopped at this point due to data saturation.  Twenty 
participants were interviewed in round 1 and 12 in round 2.  The mean length of interviews was 
51 + 9 minutes for round 1, and 37 + 10 minutes for round 2.  Demographic characteristics of the 
HPN patients are shown in Table 1.  Nearly all the participants were Caucasian (n=31) and the 
majority was female (n=23).  The most common medical diagnosis associated with the need for 
HPN was short bowel syndrome (n=22).  Nearly all participants infused parenteral nutrition daily. 
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 Three themes emerged with respect to the understanding of instructions, items, and 
response scale: (1) concerns with tone, (2) issues with ambiguity and meaning, and (3) concerns 
with use of jargon or word choice.  With respect to tone, participants voiced concern about the 
phrases "normal lifestyle", "controls my life", and "limits my freedom" and suggested that 
questions using these words would be difficult to answer because the definitions were subject to 
interpretation.  These phrases elicited unfavorable comments indicating the tone of the item was 
overly negative.  Participants inconsistently interpreted some items due to ambiguity and unclear 
meaning.  For example, several participants requested clarification around the meaning of the 
phrase "many times" and quantified "many times" very differently.  Clarification was also 
needed for words such as "satisfied" or "coping".  With respect to jargon or word choice, 
participants recommended more commonly used words for medical terms, such as "ostomy bag" 
for "ostomy appliance" and "central line" for "catheter". 
 Participants viewed the HPN-PROQ as being useful and described the items as 
"beneficial", "human", and "empathetic".  They were, however, unsure if clinicians would take 
the time to address all of their concerns.  A few representative quotations are shown below: 
• “I think these questions are phenomenal. I think they nail it…doctors don’t ask that 
(these questions) ...but this feels so human and full of empathy, I really appreciate this 
kind of questions.” 
• “A lot of times the patients want to talk about how they feel, but the physicians don’t.” 
• “They know the medical “ins and outs” in terms of intestine and bowels, but they are 
clueless to what the TPN patient goes through emotionally and physically.” 
• “I think it’s excellent, it gives somebody topics to focus on when you’re at the doctor and 
you have many questions to ask and then you go home and you remember that you forgot 
to ask some question… so I think it’s a great conversation starter.” 
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 Participants strongly agreed with the QOL definition and repeated the phrase verbatim 
when asked to restate it in their own words. For example, one participant stated, "I think it's very 
clear ... it pretty much sums it up.  I like that statement"; while another agreed by saying, "I think 
good quality of life means being able to do what I want to do".  
Participants found the 4-point Likert scale difficult to interpret the middle response 
options.  In the initial draft of the HPN-PROQ, for the first 36 items, respondents were asked, 
"during the past two weeks, how often have you experienced any of the following situations?"  
The response options were "not at all", "two to three days per week", "more than half of days", or 
"nearly every day".  For items 37-54, respondents were asked "how true or false is each of the 
following statements for you?"  The response options were "definitely false", "mostly false", 
"mostly true", and "definitely true".  Participants described the response option of "two to three 
days per week" as "three to four days per week", "maybe six times", "I would say four days per 
week", "more than seven days", and "anywhere between eight to 13 days".  Similar concerns 
were expressed for "mostly true" and "mostly false".  These inconsistencies demonstrated that 
revision to the response scale was necessary.  A visual analog scale (VAS) with the stems "not at 
all" and "every day" and "definitely false" and "definitely true" replaced the 4-point Likert scale 
in the revised HPN-PROQ.   Via member checking, all participants (n=20) provided feedback on 
the VAS and the majority (n=16) agreed with the revisions and preferred the VAS scale to the 4-
point Likert scale.  They described the VAS as "better", "less time consuming", "a great visual", 
and "more accurate".   
 Fifty-four percent of items in the initial draft of the HPN-PROQ were deemed as being 
comprehensible, acceptable, and clear as they were interpreted as intended.   Twenty-five percent 
of the items were revised and 11% deleted.  In addition to the changes driven by the iterative 
process, structural revisions were made to the questionnaire including rewording of instructions 
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and moving some items to the true/false section.  For example, "I feel supported by my family 
and friends", "I eat and enjoy the foods I want to eat", and "I am confident with my ability to 
perform TPN procedures on my own" were more easily answered as "definitely true" or 
"definitely false" rather than "every day" or "not at all". 
Phase 2 – Content Validity Index 
 In phase 2, 13 expert HPN clinicians including 2 physicians, 3 pharmacists, 3 registered 
dietitians, 2 registered nurses, and 3 home care advocates participated in evaluating the revised 
HPN-PROQ with the CVI technique.  A reduced panel of 4 expert clinicians (1 physician, 1 
registered dietitian, 1 pharmacist, and 1 home care advocate) completed a second round 
assessment.  Individual, adjusted, multi-rater K scores were examined for each of the PRO items 
as shown in Table 2. There were 34 items scoring “excellent” with I-CVI score ≥ 0.783; nine 
items with low relevance were deleted based on I-CVI score < 0.783.  The average of all I-CVI 
scores produced an S-CVI score of 0.96.  
Discussion 
 PRO questionnaires increase awareness of health related quality of life by both patients 
and clinicians and facilitate discussion of treatment goals and expectations.19 Many factors 
influence the QOL of HPN patients, and clinicians need to have the tools necessary to provide 
both medical and psychosocial support.  Researchers agree that assessment of QOL among HPN 
patients should be conducted with a therapy-specific instrument. 1,2,39 Currently, only one 
validated instrument exists for use with HPN dependent adults; this questionnaire produces a 
composite score that can be used in research for comparison over time and between treatment 
groups.10,40  
 The HPN-PROQ may offer a more clinically relevant approach to identify and address 
lifestyle concerns when used with individual patients in a medical office or home care setting.  
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We suggest that the HPN-PROQ be completed prior to an office or home care visit, in a similar 
way to a medical review of systems, at routine intervals or whenever there are important QOL 
issues to discuss.  Rather than producing an overall composite QOL score, responses could be 
used to help patients prioritize important lifestyle issues they may wish to discuss with their 
clinician and provide an opportunity for more in-depth discussion as to why they are feeling the 
way they are feeling.   
 Validation of newly developed instruments is a rigorous process that includes the 
establishment of content validity.25 Government guidelines recommend the inclusion of 
substantial patient input in PRO development.22 Sample characteristics should reflect the patient 
population to be included in future studies or in clinical practice.41 Cognitive interviewing is a 
commonly employed evidence-based research method to improve content validity of newly 
developed instruments because it assesses whether common terms are understood by the target 
population.42 In this study, we used qualitative measures to establish content validity in a 
homogeneous group of adult HPN dependent adults.  The demographic characteristics, diagnoses, 
length of HPN dependency, and parenteral nutrition infusion schedule compare favorably to 
similar studies20,31 and to a cohort of adult HPN patients enrolled in the Sustain registry.11  
We identified item-specific issues with lack of clarity regarding word choice, 
comprehension, and ambiguity and uncovered unfavorable and potentially problematic items 
when HPN dependent adults evaluated the HPN-PROQ.  For example, patients suggested using 
“central line” to replace “catheter” and “emptying an ostomy bag” instead of “changing the 
appliance”.  While clinicians understand these medical terms, more patient-friendly terminology 
was preferred.   
Replacement of the Likert scale with the VAS response scale also makes the HPN-PROQ 
more “user-friendly” for both patients and clinicians.  Use of VAS in the clinical setting with 
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self-administered questionnaires is commonly used to evaluate pain, mood, and patient 
satisfaction, are advantageous in that they decrease ambiguity or response descriptors/options, 
and require less time to complete.43,44 The HPN-PROQ de-emphasizes the significance of an 
overall score and may turn attention to factors influencing QOL and lifestyle adaptation with 
HPN.   
Clinician input is also extremely important in the development of a PRO questionnaire 
and their perception of the relevance of such a tool would likely influence its use.  Five or more 
experts are required to have a valid sample for CVI.29 This study included 13 clinicians with 
expertise in HPN care and management.  Given the multidisciplinary team management of HPN, 
we recruited physicians, nurses, registered dietitians, pharmacists, and home care advocates for 
participation.45 The I-CVI of the PRO items were analyzed using conservative criteria for 
retention with only items achieving a K > 0.783 retained.  HPN experts rated most of the items in 
the PRO as highly relevant, leading to an acceptable average S-CVI score of 0.96, which is 
comparable to results from other content validation studies.32,33,38,41   
 Five items with a borderline acceptable I-CVI score of 0.77 were eliminated because of 
the previously established criterion of > 0.783.  While this reduces the number of items on the 
questionnaire and potentially decreases participant burden, elimination of these items may leave 
out some important constructs of HPN related QOL. Two food-related items were eliminated 
including “eating cause me to have gas or feel bloated” and “eating causes me to have pain”.  It 
should be noted that these items represent physical aspects of eating and those that are 
psychosocial in nature including “I eat and enjoy the foods I want to eat” and “I can participate 
comfortably in social situations where food is served” were retained.  Furthermore, the HPN-
PROQ is intended to cue the clinician to ask the patient to describe more specifically what they 
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are struggling with so it is possible that a patient who is unable to eat and enjoy food would be 
prompted to explain why. 
The results and methodology of this study are consistent with similar research using the 
CVI to establish content validity.  For example, in the validation of the Osteoporosis Risk 
Assessment Tool, 8 experts were selected from among nationally known clinicians and 
researchers holding well-respected reputations in osteoporosis risk prevention and treatment.41 
Fourteen designated experts completed the CVI to establish item relevance for a measure of 
patient-centered communication with more liberal CVI criteria (> 0.70) resulting in the removal 
of four items from the prototype questionnaire.32 Similarly, a sample of 9 experts participated in 
a content validity study to evaluate a muscle endurance questionnaire with an I-CVI criterion of  
< 0.78 resulting in the deletion of 14 items.33 
 PRO instruments enhance patient–clinician communication and inform plans of care to 
better target interventions that will improve patient outcomes.46,47 Evidence from randomized 
controlled trials suggests that the use of PROs in clinical practice is valuable in improving the 
discussion and detection of QOL constructs, but has less of an impact on how clinicians manage 
patient problems or on subsequent patient outcomes.48  Many of the reasons for this may lie in 
the ways in which PROs fit (or do not fit) into the routine ways in which patients and clinicians 
communicate with each other, how clinicians make decisions, and how healthcare is organized.  
Researchers recommend identifying ways in which PROs can be better incorporated into the 
routine care of patients by combining qualitative and quantitative methods.48   
Regardless, use of PRO instruments can provide several advantages: to alert the clinician 
to the patient’s concerns about their QOL, to clarify the patient’s priorities for care, and to 
facilitate conversation between patients and clinicians about these issues.46 This is especially 
important as patients and physicians do not always agree on which outcomes of care are most 
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important.47 For example, patients with multiple sclerosis are less concerned than their clinicians 
about physical disability in their illness and are more concerned with issues impacting their 
QOL.49  Studies have also shown that provision of PRO feedback to clinicians results in an 
increase use of health services and referrals, more timely reporting and management of 
symptoms, less patient anxiety, fewer preventable emergency room and office visits or calls, 
greater patient adherence to advice, greater satisfaction with care, more effective self-
management, and more efficient use of resources.50-52 As patients may be embarrassed or 
hesitant to initiate conversations with their clinicians around psychosocial issues, having the 
HPN-PRO may facilitate important patient-centered discussions. 
 The HPN-PROQ illustrates acceptable content validity as determined by HPN patients 
and expert home care clinicians.  Future studies with psychometric testing should be conducted 
in a large sample of more diverse HPN patients to provide additional support for the conceptual 
framework of the HPN-PROQ and to determine its relevance with both short term/temporary 
HPN and long term/lifelong HPN dependency.  It may also be important to compare results from 
the HPN-PROQ to the HPN-QOL©.  Clinical utility should also be assessed to verify the impact 
of the HPN-PROQ on treatment decision-making.  Specifically, future studies should include 
observations of patient-clinician interaction while using the HPN-PROQ with an assessment of 
communication and patient and clinician satisfaction.  Additional research is necessary to 
determine the timing and frequency for which the HPN-PROQ should be administered. 
Limitations 
 There are some limitations in content validity studies that should be noted. Feedback is 
subjective, and may introduce biases to the study, that may exist among the patients, experts, and 
researchers.  Additionally, there was a demographic limitation among the HPN patients, which 
had a high rate of Caucasian females (72%).  However, there is no reason to suspect that this 
 14 
would impact the data in a way that would impair the clarity, relevance, and acceptability of the 
revised components of the HPN-PROQ.  Selection bias is likely as participants were self-selected, 
interested, and willing to participate.  Lastly, this study was conducted with adult HPN patients 
only and therefore, results cannot be generalized to pediatric patients or their parents or 
caregivers.  The reliability testing of the use of this instrument should be undertaken when used 
with larger numbers of patients in practice. 
Conclusion 
 To the best of our knowledge, this study adheres to standard procedures for content 
validation and these data provide evidence that the final version of the HPN-PROQ is a content 
valid questionnaire with relevant, clear, and understandable items and response scale.  Cognitive 
interviewing, member checking, and calculation of the CVI were utilized to demonstrate the 
content validity of the HPN-PROQ. The methodology (i.e. interview scripts, iterative analysis, 
actions taken to delete or modify an item in response to CI, and member checking) is appropriate 
to assess content validity.  These methods help provide a valid set of items which will in-turn 
increase the likelihood of reliable responses when used by HPN patients. Overall, most of the 
items included in the original HPN-PROQ were understood by HPN patients and interpreted as 
intended by the researchers. The questions were described as “clear” and “easy to answer” and 
represented important areas in the lives of HPN patients. 
 Although the primary intent of the cognitive interviews was to evaluate if HPN patients 
in our sample understood the items and could offer congruent interpretations, we also confirmed 
the desire by HPN patients to use the HPN-PROQ.  Study participants frequently expressed their 
gratitude for the project and were eager to participate; repeatedly commenting on the relevance 
of the issues raised in the HPN-PROQ and that effective communication with their clinicians 
about these issues is meaningful to them.  This study found that patients perceived the need for 
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an instrument such as the HPN-PROQ, which could be used to facilitate communication among 
HPN patients and their clinicians to assist in the improvement of patient-care. 
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Table 1.  Demographic Characteristics of Home Parenteral Nutrition Patients (n=32) 
Characteristic    Results  
 




   Male       9 (28%) 
 
   Female     23 (72%) 
 
Race 
   
   Caucasian     31  (97%) 
 
   Indian       1  ( 3%) 
 
Highest Level of Education 
 
   High School Diploma   15  (47%) 
 
   Associate Degree      2  ( 6%) 
 
   Bachelor Degree      7  (22%) 
 
   Master Degree                 6  (19%) 
 
   Doctoral Degree      2  ( 6%)  
 
Medical Diagnosis and Reason for Home Parenteral Nutrition 
 
   Short Bowel Syndrome   22  (69%) 
 
   Gastroparesis      3  ( 9%) 
 
   Pseudo Obstruction      4  (13%) 
 
   Other        3  ( 9%)      
 
Length of HPN Dependency (years)   12 + 10 (1 – 34)  
 
Parenteral Nutrition Infusions per week 6.5 + 1.1  (6 - 7) 
 
Parenteral Nutrition Infusion (hours)     12 + 4 (11 - 16)  
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Table 2.  Patient Reported Outcome (PRO) Item-Content Validity Index (I-CVI) Rating by 
Expert Clinicians (n=13) 
 
 
Item # - PRO Number of 
Experts Rating 
PRO  
as “3” or “4” 
K* 
Section 1.  During the past 2 weeks, please estimate how often 
you experienced any of the following situations. 
  
1. I felt like my health limited the things I want to do in my life. 13 1.00 
2. Being on TPN was difficult to cope with emotionally. 13 1.00 
3. My daily activities were limited by my TPN infusion 
schedule. 
11 0.85 
4. Carrying my TPN solution limited what I could do. 10 0.77 
5. I felt physically strong. 10 0.77 
6. I was able to participate in the activities I enjoy. 12 0.92 
7. I was able to walk without difficulty. 11 0.85 
8. I was able to climb up and down stairs without difficulty 9 0.69 
9. I was able to rise from a chair or bed without difficulty. 12 0.92 
10. I was able to pick up an object from the floor without 
difficulty. 
8 0.62 
11. I needed to nap when I felt tired. 7 0.54 
12. I had enough strength and stamina to do daily chores or work. 12 0.92 
13. The TPN pump disrupted my sleep. 13 1.00 
14. My sleep was disrupted because I had to get up to move my 
bowels or empty my ostomy bag. 
12 0.92 
15. My sleep was disrupted because I had to get up to urinate. 13 1.00 
16. I ate comfortably in social situations and around others. 12 0.92 
17. Eating caused me to have gas or feel bloated. 10 0.77 
18. Eating caused me to have pain. 10 0.77 
19. I had episodes of uncontrollable diarrhea. 12 0.92 
20. I had to move my bowels shortly after I ate food. 10 0.77 
21. I had to rearrange my daily plans because of how much 
diarrhea I had. 
12 0.92 
22. I had episodes of uncontrollable ostomy leakage. 13 1.00 
23. I had to empty my ostomy bag shortly after I ate food. 9 0.69 
24. I had to rearrange my daily plans because of how much 




Section 2.  How TRUE or FALSE are the following statements to 
you? 
  
1. Good quality of life means being able to do what I want to do 
when I want to do it. 
11 0.85 
2. I eat and enjoy the foods I want to eat. 11 0.85 
3. I am confident in my ability to perform TPN procedures on 
my own. 
13 1.00 
4. Having one or more nights or days without TPN is important 
to me.  
13 1.00 
5. Having a shorter TPN infusion schedule is important to me. 13 1.00 
6. I feel relieved knowing my nutritional needs are being met by 
TPN therapy. 
13 1.00 
7. I am fearful of developing complications related to my TPN 
therapy and/or central line. 
12 0.92 
8. I understand my need for being on TPN therapy. 13 1.00 
9. I know and have been trained on how to manage my TPN 
therapy. 
13 1.00 
10. I know and have been trained on how to care for my central 
line. 
13 1.00 
11. I know and have been trained on how to use my pump. 13 1.00 
12. I know and have been trained on the signs and symptoms of a 
central line infection. 
13 1.00 
13. I know and have been trained on signs and symptoms of 
dehydration. 
13 1.00 
14. I know and have been trained about my diet and what I should 
be eating. 
13 1.00 
15. I know whom to call when I have questions about my TPN 
therapy. 
13 1.00 
16. I feel emotionally supported by my family and friends. 12 0.92 
17. I feel well supported by my home care specialists. 13 1.00 
18. I received information about local or national support groups 
for TPN therapy. 
13 1.00 
19. I wish I knew more about my TPN therapy. 12 0.92 
 
I-CVI, Item-level content validity index; K, kappa; PRO, Patient Reported Outcome; TPN total 
parenteral nutrition 
 
*K computed using the formula K = (I-CVI-Pc)/1-Pc) where Pc = probability of a chance 
occurrence.  Items were retained with K > 0.783.  Interpretation criteria for K based on: Polit DF, 
Beck CT. The content validity index: are you sure you know what's being reported? critique and 
recommendations. Res Nurs Health. 2006;29:489-497.   
 
 
 
 
